WO2012080992A3 - Cosmetic use of essential oil of bupleurum fruticosum - Google Patents

Cosmetic use of essential oil of bupleurum fruticosum Download PDF

Info

Publication number
WO2012080992A3
WO2012080992A3 PCT/IB2011/055753 IB2011055753W WO2012080992A3 WO 2012080992 A3 WO2012080992 A3 WO 2012080992A3 IB 2011055753 W IB2011055753 W IB 2011055753W WO 2012080992 A3 WO2012080992 A3 WO 2012080992A3
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic use
essential oil
fruticosum
bupleurum
bupleurum fruticosum
Prior art date
Application number
PCT/IB2011/055753
Other languages
French (fr)
Other versions
WO2012080992A2 (en
Inventor
Pascale Pelletier
Pierre Lartaud
Agnès PEGEON
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2012080992A2 publication Critical patent/WO2012080992A2/en
Publication of WO2012080992A3 publication Critical patent/WO2012080992A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to the cosmetic use of at least one extract of at least one plant of the species Bupleurum fruticosum L. for preventing and/or treating the signs of ageing of the skin.
PCT/IB2011/055753 2010-12-17 2011-12-16 Essential oil of bupleurum WO2012080992A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1060746A FR2968987B1 (en) 2010-12-17 2010-12-17 BUPLEVRE ESSENTIAL OIL
FR1060746 2010-12-17
US201161436206P 2011-01-26 2011-01-26
US61/436,206 2011-01-26

Publications (2)

Publication Number Publication Date
WO2012080992A2 WO2012080992A2 (en) 2012-06-21
WO2012080992A3 true WO2012080992A3 (en) 2012-09-07

Family

ID=44507645

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/055753 WO2012080992A2 (en) 2010-12-17 2011-12-16 Essential oil of bupleurum

Country Status (2)

Country Link
FR (1) FR2968987B1 (en)
WO (1) WO2012080992A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6382197B2 (en) * 2012-08-20 2018-08-29 ロレアルＬ′Ｏｒｅａｌ Laserpidiumsiler L. for signs of skin aging and as an antioxidant. Usage of essential oils
FR2994528B1 (en) * 2012-08-20 2014-11-28 Oreal COSMETIC USE OF THE ESSENTIAL OIL OF LASERPITIUM SILER L. AGAINST THE SKIN SIGNS OF AGING.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0972508A1 (en) * 1997-10-07 2000-01-19 Shiseido Company Limited Extracellular matrix production promoter
JP2000178168A (en) * 1998-12-18 2000-06-27 Ichimaru Pharcos Co Ltd Elastase activity inhibitor and cosmetic composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2796990B2 (en) 1989-05-10 1998-09-10 株式会社資生堂 Skin cosmetics
FR2814950B1 (en) 2000-10-05 2003-08-08 Oreal USE OF AT LEAST ONE EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY, IN COMPOSITIONS FOR TREATING SKIN SIGNS OF AGING

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0972508A1 (en) * 1997-10-07 2000-01-19 Shiseido Company Limited Extracellular matrix production promoter
JP2000178168A (en) * 1998-12-18 2000-06-27 Ichimaru Pharcos Co Ltd Elastase activity inhibitor and cosmetic composition

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ACTA PHARMACEUTICA HUNGARICA 2004 LNKD- PUBMED:16318226, vol. 74, no. 3, 2004, pages 166 - 170, ISSN: 0001-6659 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 2004, LEMBERKOVICS EVA ET AL: "[Influence of extraction methods on the composition of essential oils].", XP002658377, Database accession no. NLM16318226 *
EVERGETIS E ET AL: "Chemical composition and larvicidal activity of essential oils from six Apiaceae family taxa against the West Nile virus vector Culex pipiens", PARASITOLOGY RESEARCH ; FOUNDED AS ZEITSCHRIFT FÜR PARASITENKUNDE, SPRINGER, BERLIN, DE, vol. 105, no. 1, 26 February 2009 (2009-02-26), pages 117 - 124, XP019716229, ISSN: 1432-1955 *
I. LORENTE ET AL: "Bioactivity of the Essential Oil of Bupleurum fruticosum", JOURNAL OF NATURAL PRODUCTS, vol. 52, no. 2, 1 March 1989 (1989-03-01), pages 267 - 272, XP055006164, ISSN: 0163-3864, DOI: 10.1021/np50062a008 *
MANUNTA A: "Bupleurum fruticosum L (fam. Umbelliferae)", ACTES- COLLOW. INT. PLANT. AROMAT. MED. MAROC,, 1 January 1985 (1985-01-01), pages 271 - 284, XP009151760 *
MANUNTA A: "Secretory tissues and essential oil composition of Bupleurum fruticosum L", JOURNAL OF ESSENTIAL OIL RESEARCH,, vol. 4, no. 5, 1 January 1992 (1992-01-01), pages 461 - 466, XP009151757, ISSN: 1041-2905 *
MOHAMED L ASHOUR ET AL: "Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action", JOURNAL OF PHARMACY AND PHARMACOLOGY, ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN, GB, vol. 63, no. 3, 16 November 2010 (2010-11-16) - 1 March 2011 (2011-03-01), pages 305 - 321, XP009151747, ISSN: 0022-3573, [retrieved on 20101116], DOI: 10.1111/J.2042-7158.2010.01170.X *
PISTELLI L ET AL: "Constituents of Bupleurum spp. from Italian flora: isolation, structure elucidation and their biological activity", RECENT RES. DEV. PHYTOCHEM,, vol. 2, 1 January 1998 (1998-01-01), pages 463 - 483, XP009151744 *

Also Published As

Publication number Publication date
FR2968987B1 (en) 2013-04-26
FR2968987A1 (en) 2012-06-22
WO2012080992A2 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
EA201291031A1 (en) METHOD OF TREATING OBESITY WITH THE USE OF ANTIOXIDANT INFLAMMATION MODULATORS
MX359327B (en) Methods and compositions for treating huntington's disease.
UA109123C2 (en) PROBIOTIC COMPOSITION FOR THE APPLICATION IN THE TREATMENT OF INTESTINAL INFLAMMATION
WO2014052836A3 (en) Methods and compositions for treating infection
BR112013016535A2 (en) plant extracts for the treatment and prevention of infections
IN2015DN02634A (en)
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2011091366A3 (en) Methods of treating or preventing periodontitis and diseases associated with periodontitis
BR112013006232A2 (en) cosmetic treatment process, compound and cosmetic composition
WO2012050745A3 (en) Compositions containing zinc pca and anogeissus extract
EP3352755A4 (en) Novel compositions and methods for treating or preventing dermal disorders
MX2017007868A (en) Compositions for providing improved sunscreen protection.
WO2013123249A3 (en) Formulations and methods for treating ear conditions
MX2014009750A (en) Antifungal compositions for the treatment of skin and nails.
BR112013012504A2 (en) method for the treatment of neurological conditions with nerium or thevetia species extract
WO2012017321A3 (en) Treatment for dyslipidemia
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
MX359181B (en) Collagen hydrolysate and use thereof.
EP2542057A4 (en) Compositions and methods for treating or preventing immuno-inflammatory disease
EP2538963B8 (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
EP2597949A4 (en) Sub-micron compositions
IN2015KN00370A (en)
WO2014090524A3 (en) Active substances for skin lightening ii
BR112015006272A2 (en) '' cosmetic use, compounding, cosmetic composition and method of cosmetic treatment ''
WO2012080992A3 (en) Cosmetic use of essential oil of bupleurum fruticosum

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11810666

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11810666

Country of ref document: EP

Kind code of ref document: A2